Lignocellulosic biomass as renewable feedstock for biodegradable and recyclable plastics production: A sustainable approach

T Raj, K Chandrasekhar, AN Kumar, SH Kim - Renewable and Sustainable …, 2022 - Elsevier
Rapid increment in fossil-derived single-use plastic disposal has led to human-made plastic
mountains and leading to ecological imbalance. Therefore, the development of alternative …

The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and …

M Greenhawt, EM Abrams, M Shaker, DK Chu… - The Journal of Allergy …, 2021 - Elsevier
Concerns for anaphylaxis may hamper severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) immunization efforts. We convened a multidisciplinary group of international …

Advances and highlights in allergic rhinitis

Y Zhang, F Lan, L Zhang - Allergy, 2021 - Wiley Online Library
Allergic rhinitis (AR) is a growing public health, medical and economic problem worldwide.
The current review describes the major discoveries related to AR during the past 2 years …

Update on pathomechanisms and treatments in allergic rhinitis

Y Zhang, F Lan, L Zhang - Allergy, 2022 - Wiley Online Library
Allergic rhinitis (AR) is a global health problem with increasing prevalence and association
with an enormous medical and socioeconomic burden. New recognition of immune cells …

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines

M Sokolowska, T Eiwegger, M Ollert, MJ Torres… - Allergy, 2021 - Wiley Online Library
The first approved COVID‐19 vaccines include Pfizer/BioNTech BNT162B2, Moderna
mRNA‐1273 and AstraZeneca recombinant adenoviral ChAdOx1‐S. Soon after approval …

Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activation

L Klimek, N Novak, B Cabanillas, M Jutel, J Bousquet… - Allergy, 2021 - Wiley Online Library
Following the emergency use authorization of the mRNA‐1273 vaccine on the 18th of
December 2020, two mRNA vaccines are in current use for the prevention of coronavirus …

Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives

V Sampath, G Rabinowitz, M Shah, S Jain, Z Diamant… - Allergy, 2021 - Wiley Online Library
Vaccines are essential public health tools with a favorable safety profile and prophylactic
effectiveness that have historically played significant roles in reducing infectious disease …

Current evidence in SARS-CoV-2 mRNA vaccines and post-vaccination adverse reports: knowns and unknowns

DS Mouliou, E Dardiotis - Diagnostics, 2022 - mdpi.com
The novel mRNA vaccinations against COVID-19 are gaining worldwide attention for their
potential efficacy, as well as for the diagnosis of some post-vaccination-reported adverse …

The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19

Y Gao, I Agache, M Akdis, K Nadeau… - International …, 2022 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic causes an overwhelming
number of hospitalization and deaths with a significant socioeconomic impact. The vast …

Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI

L Klimek, KC Bergmann, R Brehler, W Pfützner… - Allergo journal …, 2021 - Springer
Background For the preventive treatment of the 2019 coronavirus disease (COVID-19) an
unprecedented global research effort studied the safety and efficacy of new vaccine …